Trial Profile
Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities-A Phase II Multi-center Randomised Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Alprostadil (Primary)
- Indications Arteriosclerosis obliterans
- Focus Therapeutic Use
- Sponsors Yipinhong Pharmaceutical
- 08 Mar 2017 Status changed from not yet recruiting to recruiting.
- 14 Sep 2016 New trial record